A Randomized, Double Blind, Placebo Controlled Phase III Study of Fruquitinib in Combination With Paclitaxel in Second Line Gastric Cancer
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 31 Jul 2017
At a glance
- Drugs Fruquintinib (Primary) ; Paclitaxel
- Indications Gastric cancer
- Focus Registrational; Therapeutic Use
- Acronyms FRUTIGA
- Sponsors Hutchison MediPharma
- 31 Jul 2017 According to a Chi-Med media release, Phase III trial will be initiated in late 2017 or early 2018 in China.
- 18 Jul 2017 Status changed from planning to not yet recruiting.
- 08 Mar 2017 New trial record